Lung Biopsy Device Market Scope
A biopsy is a method used to remove a piece of tissue or cells from the body for examination under a magnifier. A lung biopsy is a procedure during which samples of lung tissue are removed (with a special biopsy needle or during surgery) to see if lung disease or cancer is there. A lung biopsy is also performed using either a closed or an open technique. Closed method is performed either through the skin or through the trachea (windpipe). An open biopsy is performed in the operating theatre under general anaesthesia. The most common types biopsy methods include: (1) incisional biopsy- only a sample of tissue is removed; (2) excisional biopsy- an entire lump is removed; & (3) needle biopsy- a sample of tissue or fluid is removed using a needle.
The Lung Biopsy Device market study is segmented by Type (Needle-based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Needles, Vacuum-assisted Biopsy Devices), Localization Wires, Procedure Trays and Others), by Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Others) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition and changing of consumer spending patterns and need pose significant opportunities for market growth. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Lung Biopsy Device market throughout the predicted period.
C. R. Bard, Inc. (United States), Becton, Dickinson and Company (United States), Cook Group Incorporated (United States), Devicor Medical Products, Inc (Germany), Argon Medical Devices (United States), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (United States), Olympus Corporation (Japan) and Intuitive Surgical, Inc (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Boston Scientific Corporation (United States), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (United States) and Medtronic plc (Ireland).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Lung Biopsy Device market by Type, Application and Region.
On the basis of geography, the market of Lung Biopsy Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In 2019, Food and Drug Administration (FDA) approved Instinctive Surgical Incís Ion Endoluminal Lung Biopsy System, a robot-assisted lung biopsy device which uses an ultra-thin articulating robotic catheter.
- Needle-based Biopsy Instruments is in demand for its properties such as acquiring samples from soft tissues of internal organs, such as breasts, kidneys, and lungs
- Improving Healthcare Infrastructure
- Increasing Healthcare Spending
- Increasing Number of Chronic Medical Sicknesses
- Untapped Market of Developing Countries
- High Costs Associated with Lung Biopsy
- Lack of Awareness of Lung Biopsy Among Certain Set of Population
- Strict Regulation for the Use of Biopsy
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Lung Biopsy Device Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries, Biopharmaceutical Companies and Oncology Centers
Frequently Asked Questions (FAQ):
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Lung Biopsy Device Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.